X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - 08/07/2024 21:39

Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide

MONDAY, July 8, 2024 -- Tirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.Patricia J. Rodriguez, Ph.D...

Articles similaires

Sorry! Image not available at this time

Weight loss injections vs. Weight loss surgery: Study finds surgery takes the lead over injections

wn.com - 21/Oct 13:20

In recent years, weight loss injections have become a global trend, with millions turning to popular GLP-1 medicines such as semaglutide and...

Semaglutide protects the heart beyond weight loss, SELECT trial shows

news.medical.net - 23:32

Semaglutide lowered the risk of major adverse cardiovascular events across all body weight and waist circumference levels in people with overweight or...

Sorry! Image not available at this time

Two-Dose Recombinant Zoster Vaccine Effective in Older Adults, Regardless of Prior Vaccination

drugs.com - 20/Oct 16:10

MONDAY, Oct. 20, 2025 -- Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including immunocompromised adults,...

70% of U.S. adults have obesity, study finds

knowridge.com - 17/Oct 10:48

A new way of defining obesity could dramatically change how many Americans are considered to have the condition. According to research from Mass...

70% of U.S. adults have obesity, study finds

knowridge.com - 17/Oct 10:48

A new way of defining obesity could dramatically change how many Americans are considered to have the condition. According to research from Mass...

Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers

oncologynews.com.au - 23/Oct 23:35

Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and...

Sorry! Image not available at this time

Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model

mangaloremirror.com - 10:55

NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction  NMRA-215 demonstrated best-in-class...

Sorry! Image not available at this time

Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model

mangaloremirror.com - 10:55

NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction  NMRA-215 demonstrated best-in-class...